Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Archives of Dermatological Research|October 6, 2006
The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumabCarlo Pincelli, Eric Henninger, Florence Casset-SemanazExperimental Dermatology|April 27, 2018
Progress in melanoma modelling in vitroAlessandra Marconi, Marika Quadri, Annalisa Saltari, et al.The Journal of Dermatological Treatment|June 19, 2019
Dermocosmetics: beneficial adjuncts in the treatment of acne vulgarisElena Araviiskaia, Jose Luis Lopez Estebaranz, Carlo PincelliClinical, Cosmetic and Investigational Dermatology|December 22, 2022
The Role of a Novel Generation of Emollients, 'Emollients Plus', in Atopic DermatitisElena Araviiskaia, Carlo Pincelli, Adele Sparavigna, et al.The Journal of Investigative Dermatology|January 22, 2003
Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8Mario Puviani, Alessandra Marconi, Emanuele Cozzani, et al.International Journal of Molecular Sciences|July 24, 2019
Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?Elisabetta Palazzo, Alessandra Marconi, Carlo Pincelli, et al.The Journal of Dermatological Treatment|March 2, 2026
Soluble Fas Ligand, an overlooked target of therapy in dermatological and non-dermatological conditionsRoberta Lotti, Brydon Bennett, Alessandra Marconi, et al.International Journal of Molecular Sciences|April 17, 2025
IL-17 Ligand and Receptor Family Members Are Differentially Expressed by Keratinocyte Subpopulations and Modulate Their Differentiation and Inflammatory PhenotypeElisabetta Palazzo, Roberta Lotti, Marika Quadri, et al.The Journal of Dermatological Treatment|May 22, 2025
A practical algorithm for the treatment of mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe: expert recommendationsMatthias Augustin, Thomas Luger, Carlo Pincelli, et al.Journal of Drugs in Dermatology : JDD|August 21, 2018
Mechanisms Underlying the Clinical Effects of Apremilast for PsoriasisCarlo Pincelli, Peter H Schafer, Lars E French, et al.Pageof 7